For example, application 1411 was underpinned by the evidence linking BRCA1/2 testing in breast cancer probands, and this was used to support public funding for BRCA1/2 testing in breast cancer probands and ovarian cancer probands. This evidence concerns the gene BRCA1 and breast cancer.